Genmab A/S GMAB
$ 20.56
0.51%
Quarterly report 2022-Q2
added 08-10-2022
Genmab A/S Balance Sheet 2011-2024 | GMAB
Annual Balance Sheet Genmab A/S
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | -6.94 B | -3.37 B | -533 M | -1.35 B | -307 M | -874 M | -359 M | -166 M | -61.3 M | -53.4 M |
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
- | - | 26 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | 769 M | 158 M | 3.29 M | 3.63 M | - | 1.43 M | 178 M | 165 M | 126 M | 101 M |
Total Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | 2.02 B | 1.1 B | 447 M | 331 M | 412 M | 416 M | 834 M | 1.07 B | 1.31 B | 1.08 B |
Deferred Revenue |
- | 26 M | - | - | 151 M | 228 M | 283 M | 550 M | 817 M | 1.09 B | - |
Retained Earnings |
- | 7.11 B | 2.13 B | -197 M | -1.85 B | -3.11 B | -4.23 B | -5.03 B | -5.36 B | -5.48 B | -5.01 B |
Total Assets |
- | 21.1 B | 15.1 B | 8.46 B | 6.6 B | 5.24 B | 3.9 B | 2.87 B | 1.73 B | 1.69 B | 1.56 B |
Cash and Cash Equivalents |
- | - | 3.55 B | 533 M | 1.35 B | - | - | - | - | - | - |
Book Value |
- | 19.1 B | 14 B | 8.01 B | 6.27 B | 4.83 B | 3.49 B | 2.03 B | 660 M | 383 M | 486 M |
Total Shareholders Equity |
- | - | 14 B | 8.01 B | 6.27 B | - | - | - | - | - | - |
All numbers in DKK currency
Quarterly Balance Sheet Genmab A/S
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | 554 M | - | 363 M | - | 363 M | - | 277 M | - | 313 M | - | 155 M | - | 163 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | 1.05 B | - | 863 M | - | 880 M | - | 769 M | - | 803 M | - | 158 M | - | 166 M | - | 3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | 2.99 B | - | 2.43 B | - | 2.23 B | - | 2.02 B | - | 2.81 B | - | 1.1 B | - | 691 M | - | 447 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | 12.2 B | - | 10 B | - | 8.16 B | - | 7.11 B | - | 5.88 B | - | 2.13 B | - | 32 M | - | -198 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | 27.5 B | - | 24.6 B | - | 22.5 B | - | 21.1 B | - | 20.7 B | - | 15.1 B | - | 8.98 B | - | 8.46 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | 9.82 B | - | 8.96 B | - | 9.48 B | - | 7.26 B | - | 6.6 B | - | 3.55 B | - | 583 M | - | 533 M | - | 1.09 B | - | 1.35 B | - | - | - | 307 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | 24.5 B | - | 22.2 B | - | 20.3 B | - | 19.1 B | - | 17.9 B | - | 14 B | - | 8.29 B | - | 8.01 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | 24.5 B | - | 22.2 B | - | 20.3 B | - | 19.1 B | - | 17.9 B | - | 14 B | - | 8.29 B | - | 8.01 B | - | 6.86 B | - | 6.27 B | - | - | - | 4.83 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in DKK currency